chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 22-Jul-2022; No adverse event; Administered the vaccine to 346 patients after the 30 day by used; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 22-Jul-2022) and NO ADVERSE EVENT (No adverse event) in a 32-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 22-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 22-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 22-Jul-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 22-Jul-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used) and PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 22-Jul-2022).    No concomitant medications were provided by the reporter.  Patient received half dose.  On 04-Jun-2022 the vials were initially stored in the refrigerator.  Vial did not undergone any temperature excursions.  No treatment medications were provided by the reporter.
9 minutes after receiving Pfizer vaccination, while in the recovery area, c/o feeling of throat / tongue swelling, with noted redness in the upper neck region just below the chin.  Able to speak without difficulty, denied SOB/pain or dizziness. Vitals were taken, WNL, AA0 x3, received ongoing monitoring. 911 was called as patient continued to c/o throat swelling, called at 1648,  arrived  @ 1658, patient was assessed, recommended transport to ED to ensure no further progression, patient declined transport, Husband was on seen at all time, agreed not to transport, waiver signed by patient.  DC from recovery area @ 1705 w/Husband, ambulating freely and with clear communication/speech.
Same arm where he received vaccine got magnetic; This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE DISCOMFORT (Same arm where he received vaccine got magnetic) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023C21A) for COVID-19 vaccination.     no medical history was reported.     On 25-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-May-2021, the patient experienced VACCINATION SITE DISCOMFORT (Same arm where he received vaccine got magnetic). At the time of the report, VACCINATION SITE DISCOMFORT (Same arm where he received vaccine got magnetic) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Treatment medications were not provided by the reporter   Reporter did not allow further contact
Intermittent chest pain, pressure, and burning x 1 week so I went to the ER  Also, bad neck pain
The evening of March 15th started experiencing twitches/spasms in my legs and arms then over my body. Symptoms started getting better in June. Took 2nd dose on July 25th and started getting twitches/spasms again also experiencing burning sensation in my right heel.  Started taking Magnesium and B12 on Aug 1st for the twitches that is still occurring.
Didn't feel good; Sore arm; Dizziness/Dizziness and vertigo getting worse; Vertigo/Dizziness and vertigo getting worse; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Sore arm), FEELING ABNORMAL (Didn't feel good), DIZZINESS (Dizziness/Dizziness and vertigo getting worse) and VERTIGO (Vertigo/Dizziness and vertigo getting worse) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Jun-2021, the patient experienced DIZZINESS (Dizziness/Dizziness and vertigo getting worse) and VERTIGO (Vertigo/Dizziness and vertigo getting worse). On an unknown date, the patient experienced MYALGIA (Sore arm) and FEELING ABNORMAL (Didn't feel good). At the time of the report, MYALGIA (Sore arm) and FEELING ABNORMAL (Didn't feel good) outcome was unknown and DIZZINESS (Dizziness/Dizziness and vertigo getting worse) and VERTIGO (Vertigo/Dizziness and vertigo getting worse) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information not provided.
RIGHT SUBJECTIVE TINNITUS RIGHT SUDDEN HEARING LOSS Slight balance issues.  Continued hearing loss and tinnitus 2 weeks following onset of symptoms and after 8 days of treatment on prednisone (5 mg) taper. Symptoms occurred immediately on onset date (4/9/2021) without other cause (e.g., no sound or disturbance to the ear).
Pfizer vaccine was not removed from the freezer at the 14 day cutoff when it is supposed to be moved to warmer fridge temperature. THis vaccine was kept in the freeaer and thawed at the 19 day mark. THe vaccine does not have stability data published after 17 days but was not yet expired or out of freezer teperature at any time other than to thaw.
Adult patient received a pediatric dose of Hepatitis A, no adverse events, no treatments needed.
This spontaneous report as received from a nurse refers to a unknown number of patients of unknown age and gender. Medical history and concurrent conditions were not reported. On an unknown date the patients were vaccinated with GARDASIL. No co-suspect and concomitant therapies were reported. The nurse reported that an unknown number of patients received improperly stored GARDASIL, on unknown dates. No adverse symptoms reported. The temperature excursion for GARDASIL, was found to be unsupported excursion with in-house stability data. This is one of several reports from the same source. Additional information has been requested.
Pt had gushing of blood from the arm immediately as soon as needle made its way out of the arm.  In addition, the patient started feeling dizzy and flushed upon going to the sitting area, whereas she had to turn back around and come back to the vaccine admin area to be closely monitored
Information has been received via a litigation article regarding a concerning a deceased male patient who in January and February of 1994 was vaccinated with RECOMBIVAX HB. An otherwise viable petition for rheumatoid arthritis vaccine injury survived the death of the petitioner even when that death was not vaccine related. The patient filed a petition on 02-JUL-1999, alleging that RECOMBIVAX vaccinations he received in January and February 1994 caused him to suffer an unspecified adverse reaction later identified as RA. He died on 09-SEP-2006 of unrelated causes. No further information is available.
Pt w/small cold. Started w/fever, uncontrollable crying & hives. Had hives & fever thru 1/27. Hives only on face & back now, was all over body, child still crying on 1/27. Saw Dr & he related sx's to Pertussis in vax. Have DT from now on.
No adverse effects reported; An unknown number of unspecified patients have been administered doses of vaccines that were improperly stored; This spontaneous report as received from a physician refers to a 11 year old patient of unknown gender. The patient's concurrent conditions, concomitant medications, pertinent medical history and drug reactions or allergies were not provided.  On 23-AUG-2017, the patient was vaccinated with an improperly stored dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9), lot # M040412 with expiration date on 30-JUN-2019 (dose and route of administration were not reported).  Since 19-MAY-2017, the administered dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) underwent multiple temperature excursions between 33 degrees Fahrenheit and 50 degrees Fahrenheit, which lasted for 16, 40, 46 or 70 hours. A digital data logger was not involved in recording the excursion. No adverse effects were reported. There was no product quality complaint involved.  This is one of several reports received from the same reporter.
Hive/swelling on left side of face, numbness/tingling left side of face Benadryl 25mg PO taken.
Development of a pityriasis rosacea-like rash on back, stomach, upper arms and upper thighs associated with mild itching; which spontaneously resolved within about 6 weeks.
Information has been received from a certified medical assistant (C.M.A.) concerning a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant therapy were not reported. On 20-MAR-2015, the patient was vaccinated with a dose of improperly stored PROQUAD (Merck), lot # K014798 (expiration date 12-MAR-2016, dose and route not reported). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information is not expected because the physician did not wish to be contacted.
increasingly off balance; 99 degree temp all week; feeling ill; Long narrow 3-4" red blood clot came out; Nose started bleeding profusely; Odd headache off & on 1st 2 days, then slowing increasing in frequency & duration & intensity. On day 5 around 10:30 pm I'd been sitting on couch a while talking on phone. Nose started bleeding profus; This is a spontaneous report from a contactable consumer (patient).   A 51-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EW0187), via an unspecified route of administration in left arm on 01Jul2021 at 14:00 (at the age of 51 years old) as single for covid-19 immunisation. Medical history included autoimmune disorder (numerous including autoimmune). The patient had known allergies to numerous; history of anaphylaxis to different non-vaccine shot and many medications, food, etc. The patient received other medications within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19. On 01Jul2021 at 18:00, patient experienced odd headache off and on 1st 2 days, then slowing increasing in frequency, duration and intensity. On day 5 around 10:30 pm (06Jul2021 22:00), she had been sitting on couch a while talking on phone. Nose started bleeding profusely. Ran to bathroom and blood squirting out right nostril w/her pulse. Long narrow 3-4" red blood clot came out. Blood everywhere, running down throat and spraying over sink/wall. Packed nose w/kleenex tightly and applied pressure. Left Kleenex in placed around 20 min, removed slowly but no blood on Kleenex which to implies bleeding was up higher or in sinuses. It was not a normal bloody nose. Day 6 (07Jul2021), headache continued, increasingly off balance, 99 degree temp all week and feeling ill. Advised to go to ER to rule out low platelets and stroke/brain bleed. The patient underwent lab tests and procedures which included pyrexia: 99 degree on 01Jul2021, sars-cov-2 test (Nasal swab): negative on 08Jul2021. The event resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care visit. Therapeutic measures were taken as a result of events with ER evaluation, CT scan. The outcome of events was recovering.
p/v pt devel urticaria & SOB & was seen @ ER;pt has improved & sx subsiding;pt devel severe burning & itching, loss of vision, dec LOC;MD state pt BP was extremely low;poss anaphylactic rxn;
Myalgia, Arthralgia, Tachycardia, chills, fatigur Narrative:
Erythema feet and hands with itching. Local swelling at injection site left arm sub Q; This is in follow-up report(s) previously submitted on 9/17/2007. Initial and follow-up information has been received from a registered nurse concerning an 16 year old female with a sulfa allergy and a history of attention deficit disorder (ADD) who on 01-AUG-2007 at 10:30 am was vaccinated intramuscularly into the left arm with a first dose of GARDASIL (Lot #658110/0525U). Concomitant vaccination on 01-AUG-2007 included hepatitis A vaccine (inactive) (HAVRIX) (Lot #AHAVB163AB) and VARIVAX (Lot #657718/0778U). Other concomitant therapy included DUAC, CONCERTA and FOCALIN. On 01-AUG-2007 the patient developed a local reaction on the left arm and an itchy rash on bottom of her feet and hands. The patient took BENADRYL which gave some relief. On 02-AUG-2007 24 hours after immunization the patient's mother called the physician to report that the patient was seen in the primary care office. The patient had erythema of the feet and hands with itching and local swelling at the VARIVAX site. The impression was urticaria from VARIVAX. The patient was treated with ZYRTEC. At the time of the report the patient had recovered. Additional information is not expected.
Patient presented to emergency department on 8/3/2021 following a syncopal episode at home.  He was experiencing shortness of breath for approximately 1 week and was found to be COVID-19 positive on 8/2/2021 prior to his presentation. During admission, he was asymptomatic for COVID-19 and was not treated for infection. He was discharged on  8/5/2021.
Light headed; Very hot; Chills; Headache; Itchy eyes; Itchy skin; This is a spontaneous report from a non-contactable consumer, the patient. A 31-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 02Sep2021 at 12:30 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. On 02Sep2021 at 12:45, the patient experienced light headed, very hot, chills, headache, itchy eyes and itchy skin. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events of light headed, very hot, chills, headache, itchy eyes and itchy skin were unknown at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pt recvd vax 23SEP93 & 2 hrs following vax devel sl raised, fine, urticarial rash on face, neck & upper chest; 25SEP93 rash had subsided; APR94 was dx w/mild case of down's synd;
Several months after receiving my shingles shot, I got shingles/Suspected vaccination failure; Several months after receiving my shingles shot, I got shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, several months after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were reported as follows: This case was reported by patient himself/herself. The age group was not reported but was selected as an adult as per vaccine indication. The age at vaccination was not reported. Several months after receiving Shingles shot, the patient got shingles. The patient was told that a small percentage would still get them after receiving the shot. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule and laboratory test confirming shingles were unknown at the time of reporting.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR093211:Same reporter. Invalid-Hearsay case.
Throat started to feel like something was stuck in it. By 7:30 was swelling and my tongue started to tingle. By 10:00 the underside of my tongue was the size of a golf ball and I headed to the emergency room.
Numbness and tingling in BLE on 8/8/21 that ascended to the pelvis. Started IVIG tx on 8/10/21 for Guillian Barre dx. Paralysis did not progress above the waist. As of 9/4/21 still paralyzed from the waist down and in rehab for therapy.
HEP A vaccine given to a patient under 1 year of life by mistake.  HEP B ordered and HEP A given.  Discovered after injection.
neuropathy; body tingles; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of NEUROPATHY PERIPHERAL (neuropathy) and PARAESTHESIA (body tingles) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046B21A and 026A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Apr-2021, the patient experienced NEUROPATHY PERIPHERAL (neuropathy) (seriousness criteria hospitalization prolonged and medically significant). 12-Apr-2021, the patient experienced PARAESTHESIA (body tingles) (seriousness criterion hospitalization prolonged). The patient was hospitalized on 12-Apr-2021 due to NEUROPATHY PERIPHERAL and PARAESTHESIA. At the time of the report, NEUROPATHY PERIPHERAL (neuropathy) and PARAESTHESIA (body tingles) had not resolved. Not Provided          About four hours after her second shot, she experienced neuropathy and body tingles. The patient had to go to the hospital and stayed there for 5 days.   Treatment included gabapentin, methylprednisolone, migraine vasodilator and B-12 shots.  Company comment : Based on current available information and the temporal association between product use and the start date of the events a causal cannot be excluded.; Sender's Comments: Based on current available information and the temporal association between product use and the start date of the events a causal cannot be excluded.
devel fever 12JUL97-102.5-103.5 no rash;temp still elevated on 14JUL97-102;
Bruising started about 3 days after vaccine and bleeding in right eye. Called hematologist for blood test.  Blood draw scheduled for Friday July 30, 2021, the blood panel showed zero platelets.  ITP no longer in remission. Dr.  prescribed Dexamethason. Dosage was through Tuesday morning August 2.  Appointment with Dr.  on Monday August 1 and platelet counts were 34, Tuesday 37, Wednesday 14. Infusion of Rituxin began Friday August 6, morning 9;30 am.  No further tests as of today 8/9/21.
I was very achey, chest tightness, severe congestion, extreme fatigue, coughing. I used a home COVID-19 test that came back positive, called and had a telehealth visit with my NP. I described my symptoms with her as well as let her know I was positive for COVID-19. I was given a prescription for Paxlovid that I started taking February 1, 2023.
after receiving the vaccine patient was feeling nausea and light-headed and he fainted on the floor 5 minutes after the vaccine administration
01/18/22 Covid symptoms started with cough, fever, body aches, chest tightness, difficulty sleeping, fatigue, sweats from fever, and towards end of it I had confusion. It was weird because I also had a fever one day and the next day I wouldn't have it. Tested positive on 01/20/22. Body aches were shorter and that lasted maybe 2 days. Confusion probably lasted since last week. The chest tightness I get on and off but generally it lasted until February. The cough lasted a little longer too; the fever lasted about 10 days on and off; the fatigue lasted up until February. All lasted except the fever and body aches. The body aches was the quickest to go away. I did a virtual visit with my Doctor because when I first got it I was concerned because I had flu like symptoms not longer after the booster.
first vaccine was lot er8731, since the vaccine my mensural cycle has been a week late or a week early and is extremely heavy with painful cramping
Racing heart while resting, tingling of the left leg, shortness of breath, redness at the injection site 8 days after injection, anxiety
Infant febrile morning of 5/18/2006 around 5:30 a.m. No other S/S per parent. Parent administered tylenol. Midday infant began seizing, mom called 911, infant transported and later pronounced dead at hospital. 7/19/06 Received death certificate which stated COD as pulmonary edema due to protracted febrile seizure. 7/28/06 Received tag-2 report from PCP.  Family had moved to another state.  Records accompanying report included vax records, Death Summary from ER & Autopsy Report.  COD stated as non-cardiogenic pulmonary edema as the result of febrile seizures/ss
Patient returns to vaccination clinic approx 30 mins after  observation period complaining of facial swelling and tongue tingling.
husband says nausea and diarrhea first. Worsened to severe back pain, numb hands, feet, elbows, and knees. Then severe abdominal cramps with severe pain in calves and thighs. Felt like shingle pain. This happened over 5 month period. She went to hospital and was just diagnosed with Guillan-Barre from neurologist. They were unsure until now what was happening. diag around 5-24-22  per husband by Dr.
Patient had a tonic clonic seizure lasting about 15 minutes at 4am 10/01/03 about 12 hours after shots were given. Then right sided focal seizure on 10/01/03 at 1pm for about 30 minutes requiring Ativan/Phenobarb. Still in hospital. The follow up states baby was discharged to home on 10/3/03.